Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Zach Koontz
Neoadjuvant Imatinib for Borderline Resectable GIST
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Related publications
Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials
Journal of Clinical Medicine
Folfirinox Neoadjuvant Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer - A Retrospective Study
International Journal of Contemporary Medical Research [IJCMR]
Meta-Analysis Comparing Upfront Surgery With Neoadjuvant Treatment in Patients With Resectable or Borderline Resectable Pancreatic Cancer
British Journal of Surgery
Surgery
A Pilot Study- Neoadjuvant Chemotherapy With Gemcitabine and S1 in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Journal of Carcinogenesis & Mutagenesis
Erratum To: Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival
Annals of Surgical Oncology
Oncology
Surgery
Significance of Neoadjuvant Chemoradiotherapy for Borderline Resectable Pancreatic Head Cancer: Pathological Local Invasion and Microvessel Invasion Analysis
Molecular and Clinical Oncology
Cancer Research
Oncology
Neoadjuvant FOLFIRINOX for Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis
Oncologist
Cancer Research
Medicine
Oncology
Sustained CA19-9 Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer Predicts Progression and Survival
Oncologist
Cancer Research
Medicine
Oncology
Cutting‐edge Strategies for Borderline Resectable Pancreatic Cancer
Annals of Gastroenterological Surgery